Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, CA 90095, USA.
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095, USA.
Cells. 2022 May 8;11(9):1583. doi: 10.3390/cells11091583.
Tumor-associated macrophages (TAMs) accumulate in the solid tumor microenvironment (TME) and have been shown to promote tumor growth and dampen antitumor immune responses. TAM-mediated suppression of T-cell antitumor reactivity is considered to be a major obstacle for many immunotherapies, including immune checkpoint blockade and adoptive T/CAR-T-cell therapies. An ex vivo culture system closely mimicking the TME can greatly facilitate the study of cancer immunotherapies. Here, we report the development of a 3D TME-mimicry culture that is comprised of the three major components of a human TME, including human tumor cells, TAMs, and tumor antigen-specific T cells. This TME-mimicry culture can readout the TAM-mediated suppression of T-cell antitumor reactivity, and therefore can be used to study TAM modulation of T-cell-based cancer immunotherapy. As a proof-of-principle, the studies of a PD-1/PD-L1 blockade therapy and a MAO-A blockade therapy were performed and validated.
肿瘤相关巨噬细胞(TAMs)在实体瘤微环境(TME)中积累,并已被证明可促进肿瘤生长和抑制抗肿瘤免疫反应。TAM 介导的抑制 T 细胞抗肿瘤反应被认为是许多免疫疗法的主要障碍,包括免疫检查点阻断和过继性 T/CAR-T 细胞疗法。体外培养系统可以很好地模拟 TME,极大地促进了癌症免疫疗法的研究。在这里,我们报告了一种 3D TME 模拟培养系统的开发,该系统由人类 TME 的三个主要成分组成,包括人类肿瘤细胞、TAMs 和肿瘤抗原特异性 T 细胞。这种 TME 模拟培养可以检测 TAM 介导的抑制 T 细胞抗肿瘤反应,因此可用于研究 TAM 对基于 T 细胞的癌症免疫疗法的调节作用。作为原理验证,我们进行并验证了 PD-1/PD-L1 阻断治疗和 MAO-A 阻断治疗的研究。